Addetia, Karima <br/><br/>
Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points.  [electronic resource] 

 -  Circulation. Cardiovascular imaging  Jan 2014 
 - 115-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1942-0080 
<br/><br/><label>Standard No.: </label>10.1161/CIRCIMAGING.113.000932  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antihypertensive Agents--therapeutic use<br/>Controlled Clinical Trials as Topic--economics<br/>Cost Savings<br/>Cost-Benefit Analysis<br/>Diagnostic Imaging--economics<br/>Drug Therapy, Combination<br/>Echocardiography, Three-Dimensional--economics<br/>Familial Primary Pulmonary Hypertension<br/>Female<br/>Health Care Costs<br/>Humans<br/>Hypertension, Pulmonary--diagnosis<br/>Magnetic Resonance Imaging, Cine--economics<br/>Male<br/>Middle Aged<br/>Models, Economic<br/>Predictive Value of Tests<br/>Sample Size<br/>Treatment Outcome<br/>Ventricular Function, Right--drug effects